The demand for CBD oil and CBD-infused products has exploded in popularity. Thanks to the countless reports supporting CBD benefits, America has become interested in CBD oil now more than ever! Last year, experts from the World Health Organization (WHO) released a study endorsing CBD benefits for several conditions including anxiety, pain, inflammation, neurological diseases, and many more. The WHO committee also emphasized how CBD displayed no indicative effects of abuse or the potential for dependence.
Researchers wrote in 2011 that one of the most important functions of endocannabinoids and CB(1) receptors are to enhance the energy storage conversion into fat and reduce energy expenditure by influencing both lipid and glucose metabolism. Although normally well controlled by hormones etc., the endocannabinoid regulation of energy balance can become dysregulated and contribute to obesity, dyslipidemia and diabetes (type 2).
There are some important points to keep in mind, though. The recent passing of the Agricultural Improvement Act of 2018 changed the classification of hemp from a Schedule I substance to an “agricultural commodity,” paving the way for hemp and hemp-derived substances to be bought and sold legally. It’s also worth pointing out that the DEA recently reclassified some CBD (with a THC content <.0%) from a Schedule I, illegal substance, to the less-restrictive Schedule 5 drugs, as long as an item has been approved by the U.S. Food and Drug Administration. Lastly, the Farm Bill lifted restrictions on sales and transportation, as well as possession of CBD derived from hemp as long as the hemp:

The previously mentioned study which established improved mitochondrial function with CBD use also observed that CBD stimulates gene expression within white fat cells. This initiates the “browning” of these cells. This mechanism shows promise with converting hard-to-lose white fat into a more easily burnable form. Additionally, researchers found that CBD decreased the rate of new fat cell creation.
Due to the many variations in monitors and online browsers, product images may appear different on different monitors. Computer monitors are not all calibrated equally and color reproduction on online is not precise. Since it is not possible to guarantee our online colors will look the same on all computers, we do not guarantee that what you see accurately portrays the color of the product images.
CBD may be best known for its relaxing, calming effects. CBD reduces autonomic arousal, having the inverse effect of THC on the body. CBD’s anti-anxiety effect is why many in the cannabis community talk about how CBD relieves paranoia, although that is not scientifically proven yet. CBD is also known for its anti-nausea and pain relieving effects. It really depends on why your body’s specific needs and the quantity in which you take CBD.
Thankfully this doesn’t apply to me personally, but studies have shown that CBD oil can be very beneficial to those who suffer from Diabetes. It does this by decreasing insulin resistance. The exact science behind this is still being researched, but some scientists believe that it is related to a cannabinoid called THCV, which has been shown to increase insulin sensitivity.
Medterra prides itself on offering what it terms “true seed-to-sale purchases,” with the hemp crop used for its CBD oil cultivated and extracted to the exacting standards demanded by the Kentucky Department of Agriculture. Potential buyers may be encouraged, too, to know that “quality, consistency and safety are… top priorities” at Medterra, and to that end all of the raw materials the company uses are independently lab tested. Plus, those who decide to take the plunge and order from the provider’s site can reap the benefits of its rewards program, with points given for Facebook shares, reviews and purchases. Among the products on offer at Medterra are CBD oil tinctures, capsules and pain-alleviating cream, all of which fall under a money-back pledge if not deemed to be to customers’ satisfaction.
The FDA also issued a warning to these companies in 2015 for making false claims of effectiveness and medicinal benefits. “Your products are not generally recognized as safe and effective,” the letter read. “Additionally, your product is offered for conditions that are not amenable to self-diagnosis and treatment by individuals who are not medical practitioners.”
×